Serum deoxyribonuclease I activity can be used as a novel marker of transient myocardial ischaemia: Results in vasospastic angina pectoris induced by provocation test

European Heart Journal

Volumn 28, Issue 24, 2007, Pages 2992-2997

  Morikawa, Norihiro ^a   Kawai, Yasuyuki ^b   Arakawa, Kenichiro ^a   Kumamoto, Teruhiko ^a   Miyamori, Isamu ^a   Akao, Hironobu ^b   Kitayama, Michihiko ^b   Kajinami, Kouji ^b   Lee, Jong Dae ^c   Takeshita, Haruo ^d   Kominato, Yoshihiko ^e   Yasuda, Toshihiro ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF FUKUI HOSPITAL   (Japan)

^d SHIMANE UNIVERSITY   (Japan)

^e GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Deoxyribonuclease I; Ischaemia; Vasospastic angina pectoris

Indexed keywords

BIOLOGICAL MARKER; DEOXYRIBONUCLEASE I; ERGOMETRINE; TROPONIN T;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLOOD CHEMISTRY; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; ENZYME ACTIVITY; FEMALE; HEART FUNCTION TEST; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROVOCATION TEST; VASOSPASTIC ANGINA PECTORIS;

AGED; ANGINA PECTORIS, VARIANT; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; DEOXYRIBONUCLEASE I; ERGONOVINE; FEMALE; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OXYTOCICS;

EID: 37149032763     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm483     Document Type: Article

References (30)

1. Wu AHB. The ischemia-modified albumin biomarker for myocardial ischemia. Med Lab Obs 2003;35:36-40.
2. Morrow DA, de Kemos JA, Sabatine MS, Antman EM. The search for a biomarker of myocardial ischemia. Clin Chem 2003;49:537-539.
3. Yasuda T, Awazu S, Sato W, Iida R, Tanaka Y, Kishi K. Human genetically polymorphic deoxyribonuclease: purification, characterization and multiplicity of urine deoxyribonuclease I. J Biochem 1990;108:393-398.
4. Kawai Y, Yoshida M, Arakawa K, Kumamoto T, Morikawa N, Masamura K, Tada H, Ito S, Hoshizaki H, Oshima S, Taniguchi K, Terasawa H, Miyamori I, Yasuda T. The diagnostic use of serum deoxyribonuclease I activity as a novel early-phase marker in acute myocardial infarction. Circulation 2004;109:2398- 2400.
5. Arakawa K, Kawai Y, Kumamoto T, Morikawa N, Masahiro Y, Tada H, Kawaguchi R, Taniguchi K, Miyamori I, Kominato Y, Kishi K, Yasuda T. Serum deoxyribonuclease I activity can be used as a sensitive marker for detection of transient myocardial ischemia induced by percutaneous coronary intervention. Eur Heart J 2005;26:2375-2380.
6. Hillis LD, Braunwald E. Coronary-artery spasm. N Engl J Med 1978;299: 695-702.
7. Maseri A, Severi S, Nes MD, L'Abbate A, Chierchia S, Marzilli M, Ballestra AM, Parodi O, Biagini A, Distante A. Variant angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Am J Cardiol 1978;42:1019-1035.
8. Yasue H, Kugiyama K. Coronary spasm: clinical features and pathogenesis. Intern Med 1997;36:760-765.
9. Kawano H, Ogawa H. Endothelial function and coronary spastic angina. Intern Med 2005;44:91-99.
10. Bertrand ME, LaBlanche JM, Tilmant PY, Thieuleux FA, Delforge MR, Carre AG, Asseman P, Berzin B, Libersa C, Laurent JM. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation 1982;65:1299-1306.
11. Hackett D, Larkin S, Chierchia S, Davies G, Kaski JC, Maseri A. Induction of coronary artery spasm by a direct local action of ergonovine. Circulation 1987;75:577-582.
12. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings. N Engl J Med 1985;312:932-936.
13. Nadano D, Yasuda T, Kishi K. Measurement of deoxyribonuclease I activity in human tissues and body fluids by a single radial enzyme-diffusion method. Clin Chem 1993;39:448-452.
14. Takeshita H, Nakajima T, Mogi K, Kaneko Y, Yasuda T, Iida R, Kishi K. Rapid quantification of DNase I activity in one-microliter serum samples. Clin Chem 2004;50:446-448.
15. Nakajima T, Yasuda T, Nakashima Y, Bosomy O, Takeshita H, Kishi K. Two novel screening methods for selecting monoclonal antibodies which specifically inhibit DNase I enzyme activity. Immunol Invest 1998;27: 145-152.
16. Hallermayer K, Klenner D, Vogel R. Use of recombinant human cardiac troponin T for standardization of third generation troponin T method. Scand J Clin Lab Invest Suppl 1999;230:128-131.
17. Müller-Bardorff M, Hallermayer K, Schröder A, Ebert C, Borgya A, Gerhardt W, Remppis A, Zehelein J, Katus HA. Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation. Clin Chem 1997;43:458-466.
18. Giannitsis E, Katus HA. Mirror, mirror on the wall: the quest for the earliest marker of myocardial ischemia. Eur Heart J 2005;26:2349- 2350.
19. Tsimikas S, Lau HK, Han KR, Shortal B, Miller ER, Segev A, Curtiss LK, Mitztum JL, Strauss BH. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein. Circulation 2004;109:3164-3170.
20. Scheinman MM, Abbott JA. Clinical significance of transmural versus nontransmural electrocardiographic changes in patients with acute myocardial infarction. Am J Med 1973;55:602-607.
21. Yamaguchi H, Homma Y, Handa S. Biochemical markers of vasospastic coronary artery disease. Nutr Metab Cardiovasc Dis 2003;13:365- 371.
22. Hung M-J, Cherng W-J, Yang N-I, Cheng C-W, Li L-F. Relation of high-sensitive C-reactive protein level with coronary vasospastic angina pectoris in patients without hemodynamically significant coronary artery disease. Am J Cardiol 2005;96:1484-1490.
23. Bar-Or D, Winkler JV, Vanbenthuysen K, Harris L, Lau E, Hetzel FW. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J 2001;141:985-991.
24. Sinha MK, Gaze DC, Tippins JR, Collinson PO, Kaski J-C. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 2003;107:2403-2405.
25. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE III, Steward DE, Theroux P. ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction. J Am Coll Cardiol 2000;36:959-969.
26. Beltrame JF, Sasayama S, Maseri A. Racial heterogeneity in coronary artery vasomotor: differences between Japanese and Caucasian patients. J Am Coll Cardiol 1999;33:1442-1452.
27. Okamoto F, Sohmiya K, Ohkura Y, Kawamura K, Asayama K, Kimura H, Nishimura S, Ishii H, Sunahara N, Tanaka T. Human heart-type cytoplasmic fatty-acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction: clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB. Clin Chem Lab Med 2000;38:231-238.
28. Pelsers MMAL, Hermens WT, Glatz JFC. Fatty-acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta 2005;352:15-35.
29. Hayasida N, Chihara S, Tayama E, Akasu K, Kai E, Kawara T, Aoyagi S. Influence of renal function on serum and urinary heart fatty-acid-binding protein levels. J Cardiovasc Surg 2001;42:735-740.
30. Goto T, Takase H, Toriyama T, Sugiura T, Sato K, Ueda R, Dohi Y. Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure. Heart 2003;89:1303-1307.